Damansara Specialist Hospital Launches Newly Renovated Oncology Daycare Unit

Damansara: Damansara Specialist Hospital, under the KPJ Healthcare group, marked Pink October 2025 with the launch of its newly renovated Oncology Daycare Unit (ODCU), as part of its efforts to enhance cancer care.

According to BERNAMA News Agency, the launch, graced by Tengku Permaisuri of Selangor, Tengku Permaisuri Norashikin, underscores another step in the hospital's ongoing efforts to improve cancer treatment and raise awareness of early detection. The ODCU provides a comprehensive range of therapies, including chemotherapy and targeted treatments such as hormone therapy, angiogenesis inhibitors, immunotherapy, and monoclonal antibodies.

It also offers bone-strengthening medication for patients with bone metastases, alongside palliative and supportive care that focuses on symptom management and quality of life. The upgraded facility now features a refreshed and calming environment with upgraded interiors and a dedicated treatment room for minor procedures. These enhancements reflect DSH's commitment to ensuring patient comfort, privacy, and holistic care, as stated in the statement.

Meanwhile, KPJ Healthcare president and managing director Chin Keat Chyuan described the upgraded facilities at the ODCU as reflecting the group's belief that quality cancer care extends beyond medical treatment. At DSH, the focus remains on enhancing services and collaborations to ensure timely screening and treatment in a safe, supportive environment.

In the same statement, head of oncology at DSH Assoc Prof Dr Aminudin Rahman Mohd Mydin highlighted that while breast cancer is one of the most treatable cancers, many cases are still diagnosed at a late stage. The trend of younger women being diagnosed, including during pregnancy, with many detected at advanced stages, underscores the need for early screening. Early detection significantly improves the survival rate, while late-stage diagnosis makes treatment more complex and costly.

Breast cancer remains the most common cancer among Malaysian women, accounting for almost a third of all cases. Despite growing awareness, late-stage diagnosis persists. DSH aims to improve access to early screening, multidisciplinary expertise, and patient education initiatives to encourage early intervention and improve outcomes.